DE1913119A1 - Alpha-Carboline und Verfahren zu ihrer Herstellung - Google Patents

Alpha-Carboline und Verfahren zu ihrer Herstellung

Info

Publication number
DE1913119A1
DE1913119A1 DE19691913119 DE1913119A DE1913119A1 DE 1913119 A1 DE1913119 A1 DE 1913119A1 DE 19691913119 DE19691913119 DE 19691913119 DE 1913119 A DE1913119 A DE 1913119A DE 1913119 A1 DE1913119 A1 DE 1913119A1
Authority
DE
Germany
Prior art keywords
group
carboline
acid
compounds according
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691913119
Other languages
German (de)
English (en)
Inventor
Cocker John Derek
Joseph Elks
Gregory Gordon Ian
Warburton William Kingston
Leslie Stevenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DE1913119A1 publication Critical patent/DE1913119A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19691913119 1968-03-15 1969-03-14 Alpha-Carboline und Verfahren zu ihrer Herstellung Pending DE1913119A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1273168A GB1268772A (en) 1968-03-15 1968-03-15 NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
GB1273068 1968-03-15

Publications (1)

Publication Number Publication Date
DE1913119A1 true DE1913119A1 (de) 1970-08-06

Family

ID=26249226

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691913119 Pending DE1913119A1 (de) 1968-03-15 1969-03-14 Alpha-Carboline und Verfahren zu ihrer Herstellung

Country Status (8)

Country Link
AT (2) AT310155B (enExample)
BE (1) BE729855A (enExample)
CH (2) CH553200A (enExample)
DE (1) DE1913119A1 (enExample)
FR (1) FR2003999A1 (enExample)
GB (1) GB1268772A (enExample)
IE (1) IE32705B1 (enExample)
NL (1) NL6903973A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5536401A (en) * 1978-06-09 1980-03-14 Japan Tobacco Inc Amino-alpha-carboline compound and mutagenic agent containing the same

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000286A (en) 1975-05-28 1976-12-28 Merck & Co., Inc. 3-Phenyl,3H 1,2,3 triazolo[4,5-b]pyridines
SE7605398L (sv) * 1975-05-28 1976-11-29 Merck & Co Inc 3h-1,2,3-trizol(4,5-b)pyridiner
FR2428642A1 (fr) * 1978-06-15 1980-01-11 Sumitomo Chemical Co Derives indolo-isoquinoleiniques
US4558132A (en) * 1982-07-02 1985-12-10 A. H. Robins Company, Incorporated Nitro, amino and aroylamino-N-phenylpyridinamines in a process for preparing pyrido[1,4]benzodiazepines
USRE37525E1 (en) 1991-05-01 2002-01-22 Henry M. Jackson Foundation Method for treating infectious respiratory diseases
CZ236494A3 (en) * 1992-04-03 1994-12-15 Upjohn Co Pharmaceutically active bicyclic-heterocyclic amines
US5502187A (en) * 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
US5369086A (en) * 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
US5783575A (en) * 1994-03-14 1998-07-21 Novo Nordisk A/S Antagonists, their preparation and use
US5696148A (en) * 1994-03-14 1997-12-09 Novo Nordisk A/S Indole compounds and their use in treating diseases of the central nervous system
EP0842176A1 (en) * 1995-07-31 1998-05-20 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
WO2001051479A2 (en) * 2000-01-07 2001-07-19 Warner-Lambert Company Tricyclic compounds with antiviral activity
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7064139B2 (en) * 2001-10-29 2006-06-20 Uniroyal Chemical Company, Inc. Method for treating retroviral infections
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
EP2161271A1 (en) * 2008-09-08 2010-03-10 Università Degli Studi Di Milano - Bicocca Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl
DK2968284T3 (da) 2013-03-14 2021-06-14 Osteoqc Inc Alkyl-amin-harminderivater til fremme af knoglevækst
WO2015110263A1 (en) * 2014-01-21 2015-07-30 Ac Immune Sa Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyolid-like proteins
CN112996506A (zh) 2018-08-14 2021-06-18 奥斯特克有限公司 吡咯并二吡啶化合物
BR112021002655A2 (pt) 2018-08-14 2021-05-04 Osteoqc Inc. compostos flúor ss-carbolina
FR3109534B1 (fr) 2020-04-22 2022-03-25 Soprema Installation et procédé de traitement de produits composites à base de matières thermoplastiques

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5536401A (en) * 1978-06-09 1980-03-14 Japan Tobacco Inc Amino-alpha-carboline compound and mutagenic agent containing the same

Also Published As

Publication number Publication date
FR2003999A1 (enExample) 1969-11-14
IE32705B1 (en) 1973-10-31
IE32705L (en) 1969-09-15
BE729855A (enExample) 1969-09-15
CH553200A (de) 1974-08-30
NL6903973A (enExample) 1969-09-17
CH561206A5 (enExample) 1975-04-30
AT310155B (de) 1973-09-25
AT304533B (de) 1973-01-10
GB1268772A (en) 1972-03-29

Similar Documents

Publication Publication Date Title
DE1913119A1 (de) Alpha-Carboline und Verfahren zu ihrer Herstellung
DE69718472T2 (de) Bicyclische heteroaromatische verbindungen als protein tyrosine kinase inhibitoren
WO2006042638A1 (de) 3,6-substituierte 5-arylamino-1h-pyidin-2-on derivative und verwandte verbindungen als poly(adp-ribose)polymerase (parp) inhibitoren zur behandlung von durch nekose oder apoptose verursachten gewebeschäden oder erkankungen
DD287497A5 (de) Verfahren zur herstellung 3(2h)-pyridazinon
DE3855549T2 (de) Benzimidazol-Derivate und therapeutische, diese enthaltende Mittel gegen Ulcer
DE69219646T2 (de) 6,9-Bis(substituiert-amino)benzo[9]isoquinoline-5,10-Dione
DD145101A5 (de) Verfahren zur herstellung von inda yl-derivaten
DE69321254T2 (de) Quinuclidin derivate als squalene synthase inhibitoren
EP0011142A1 (de) Pyrido (2,1-b) chinazolinon-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
EP0031885A1 (de) Basische Äther, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
CN102649765B (zh) 具有抗白血病活性的大黄素二正辛基季铵盐及其制备方法
DD270710A5 (de) Verfahren zum herstellen herzstimulierender chinolone
EP0363883A1 (de) Chromanderivate
DE2118315C3 (de) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
KR900001194B1 (ko) N-아미노피리디늄 베타인 유도체의 제조방법
DE10043659A1 (de) Arylpiperazinderivate
CH593281A5 (en) Antibacterial piperazine derivs and inters - prepd. from 4-substd. amino-2-substd. pyrimidine-5-carboxylic acid esters
EP0406656A1 (de) Chromanderivate
DE3038593C2 (enExample)
DE60116902T2 (de) Neue desloratadinsalze, verfahren zu deren synthese und diese enthaltende pharmazeutische zusammensetzungen
Malinowski et al. Synthesis of 4-alkylsulfanylphthalazin-1 (2H)-ones via palladium catalyzed sulfanylation of substituted 4-bromophthalazin-1 (2H)-ones
EP1007507B1 (de) Verfahren zur herstellung von 2-cyanoindan-1-onen
DE1913124A1 (de) Alpha-Carboline und Verfahren zu ihrer Herstellung
EP1311503A1 (de) Chromenonderivate und ihre verwendung zur behandlung von krankheiten im zusammenhang mit 5-hta1-rezeptoren und /oder dopamin-d2-rezeptoren
CH638525A5 (de) 3-(tetrazol-5-yl)-1-azaxanthone und verfahren zu ihrer herstellung.